Insights

Loading spinner
Gathering insights about Cyntegrity | We De-risk Clinical Trials

Cyntegrity | We De-risk Clinical Trials Tech Stack

Cyntegrity | We De-risk Clinical Trials uses 8 technology products and services including RSS, Vue.js, Modernizr, and more. Explore Cyntegrity | We De-risk Clinical Trials's tech stack below.

  • RSS
    Content Management System
  • Vue.js
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • HSTS
    Security
  • ZURB Foundation
    UI Frameworks
  • IONOS
    Web Hosting
  • The Events Calendar
    Web Platform Extensions
  • FitVids.js
    Web Tools And Plugins

Media & News

Cyntegrity | We De-risk Clinical Trials's Email Address Formats

Cyntegrity | We De-risk Clinical Trials uses at least 1 format(s):
Cyntegrity | We De-risk Clinical Trials Email FormatsExamplePercentage
First.Last@cyntegrity.comJohn.Doe@cyntegrity.com
47%
First.Middle@cyntegrity.comJohn.Michael@cyntegrity.com
3%
First.Last@cyntegrity.comJohn.Doe@cyntegrity.com
47%
First.Middle@cyntegrity.comJohn.Michael@cyntegrity.com
3%

Frequently Asked Questions

What is Cyntegrity | We De-risk Clinical Trials's official website and social media links?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's official website is cyntegrity.com and has social profiles on LinkedInCrunchbase.

What is Cyntegrity | We De-risk Clinical Trials's NAICS code?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does Cyntegrity | We De-risk Clinical Trials have currently?

Minus sign iconPlus sign icon
As of December 2025, Cyntegrity | We De-risk Clinical Trials has approximately 51 employees across 4 continents, including EuropeAfricaAsia. Key team members include Ceo & Founder: A. A.Chief Scientific Officer: J. P.Head Of Customer Success: N. A. B.. Explore Cyntegrity | We De-risk Clinical Trials's employee directory with LeadIQ.

What industry does Cyntegrity | We De-risk Clinical Trials belong to?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials operates in the IT Services and IT Consulting industry.

What technology does Cyntegrity | We De-risk Clinical Trials use?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's tech stack includes RSSVue.jsModernizrHSTSZURB FoundationIONOSThe Events CalendarFitVids.js.

What is Cyntegrity | We De-risk Clinical Trials's email format?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials's email format typically follows the pattern of First.Last@cyntegrity.com. Find more Cyntegrity | We De-risk Clinical Trials email formats with LeadIQ.

When was Cyntegrity | We De-risk Clinical Trials founded?

Minus sign iconPlus sign icon
Cyntegrity | We De-risk Clinical Trials was founded in 2013.

Cyntegrity | We De-risk Clinical Trials

IT Services and IT ConsultingHesse, Germany51-200 Employees

Cyntegrity is a premier provider of AI-augmented, risk-based quality management solutions in the BioPharma industry. Our AI journey began in 2017 with the introduction of Machine Learning predictive analytics, enhancing the accuracy and efficiency of our services. By 2020, we expanded our AI capabilities to include predictive analytics for all clinical research metrics, further refining our solutions.

In 2023, we introduced "Ask AI" for clinical risk assessment and AI-augmented regulatory inspections, streamlining our clients' operations. As we celebrate our 10th anniversary in 2024, we're proud to add AI-augmented clinical Due Diligence to our services, providing even more comprehensive solutions.

Our proprietary MyRBQM® Portal, MyRBQM® Academy, and MyRBQM® FSP brands facilitate integrated risk management. We assist sponsors, CROs, regulators, and auditors with AI-augmented data science technology, educational programs, and related functional services, allowing them to focus resources where most needed.

Cyntegrity is powered by an international team of industry specialists from 17 nationalities living in 14 countries. We aim to be the preferred provider of AI-augmented SaaS and PaaS solutions for ICH GCP E6(R3), E8(R1), and Q9(R1) compliant clinical trial risk management, change management, and risk-based regulatory oversight.

Section iconCompany Overview

NAICS Code
5415 - Computer Systems Design and Related Services
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $250M$500M

    Cyntegrity | We De-risk Clinical Trials's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Cyntegrity | We De-risk Clinical Trials's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.